A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects
Status:
Completed
Trial end date:
2009-04-27
Target enrollment:
Participant gender:
Summary
The study will investigate whether GSK1362885 is safe and well-tolerated when administered to
normal healthy subjects. The study will also measure blood levels of the study drug to
determine how the body processes the drug (pharmacokinetics) and what effects the drug has on
the body (pharmacodynamics).